For a challenging trial of intraperitoneal onlay mesh‑plus (IPOM‑plus) in elective laparoscopic ventral or incisional hernia repair in adults aged 18‑75 with BMI < 40 kg/m², defect ≤10 cm, and no intra‑abdominal infection, what patient selection criteria, mesh type, fixation technique, and peri‑operative management should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IPOM-Plus in Elective Laparoscopic Ventral/Incisional Hernia Repair

Overview of the IPOM-Plus Technique

The IPOM-plus technique—which combines intraperitoneal mesh placement with fascial defect closure—significantly reduces hernia recurrence (OR = 0.51), seroma formation (OR = 0.48), and mesh bulging (OR = 0.08) compared to standard IPOM without defect closure, making it the preferred laparoscopic approach for ventral and incisional hernias in appropriate candidates. 1

Patient Selection Criteria

Ideal Candidates

  • Adults aged 18–75 years with BMI < 40 kg/m² are optimal candidates, as BMI significantly influences postoperative recurrence rates (OR = 0.43, p < 0.0001). 1
  • Hernia defects ≤10 cm are most suitable for laparoscopic IPOM-plus repair. 1, 2
  • Clean or clean-contaminated surgical fields (CDC Class I-II) without intra-abdominal infection are essential prerequisites. 3, 4

Exclusion Criteria

  • Avoid IPOM-plus in contaminated/dirty fields (CDC Class III-IV) with gross enteric spillage, as polypropylene mesh infection rates reach 21% in these settings. 4, 5
  • Active intra-abdominal infection is an absolute contraindication to synthetic mesh placement. 3

Mesh Selection Algorithm

For Clean/Clean-Contaminated Fields (CDC Class I-II)

  • Use synthetic polypropylene mesh for all defect sizes in elective repairs without contamination. 3, 4, 5
  • Synthetic mesh provides superior long-term outcomes with significantly lower recurrence rates (OR = 0.2) compared to non-mesh repair. 3, 4
  • Dual-layer composite meshes designed for intraperitoneal placement should be selected to minimize adhesion formation. 2

For Contaminated Fields (CDC Class III)

  • For defects <3 cm with bowel necrosis or gross spillage: Primary repair without mesh is recommended. 3, 4, 5
  • For defects ≥3 cm in contaminated fields: Biological mesh is preferred when available. 3, 4, 5
  • If biological mesh is unavailable: Consider polyglactin mesh or open wound management with delayed repair. 4, 5

Fixation Technique

Defect Closure Method

  • Perform continuous laparoscopic closure of the linea alba using barbed non-resorbable 1-0 suture (polybutester) prior to mesh placement. 6
  • Transfascial sutures for defect closure reduce seroma formation and recurrence rates, making them an essential component of the IPOM-plus technique. 2
  • Complete fascial approximation restores abdominal wall anatomy and physiology before mesh reinforcement. 6

Mesh Fixation

  • Anchor mesh with transfascial sutures to achieve secure fixation and reduce mesh migration. 2
  • For suprapubic hernias: Mobilize the urinary bladder from the rectus abdominis muscle to create a compartment for mesh placement, anchor to the pubic bone, then reposition the bladder. 2
  • Ensure adequate mesh overlap of at least 5 cm beyond the defect margins in all directions. 6

Peri-operative Management

Pre-operative Considerations

  • Assess surgical field classification to determine appropriate mesh type and approach. 3, 4
  • Optimize modifiable risk factors including smoking cessation, diabetes control, and nutritional status. 7
  • Screen for chronic immunosuppression (OR = 2.41 for wound complications) and previous hernia repair (OR = 1.99 for wound complications). 7

Intra-operative Management

  • Use laparoscopic approach to benefit from lower wound infection rates compared to open repair. 4, 8
  • Evaluate hernia content viability and identify occult contralateral hernias during laparoscopy. 4
  • For complex hernias >10 cm: Consider endoscopic anterior bilateral component separation in combination with IPOM-plus. 6

Post-operative Care

  • Initiate early mobilization beginning on postoperative day 1 to reduce complications. 4
  • Resume normal activities gradually guided by comfort and wound healing. 4
  • Monitor for seroma formation, which occurs less frequently with IPOM-plus (OR = 0.48) compared to standard IPOM. 1

Critical Pitfalls to Avoid

Mesh-Related Complications

  • Never use polypropylene mesh in grossly contaminated fields (CDC Class III-IV with spillage), as infection rates reach 21%. 4, 5
  • Avoid absorbable prosthetic materials for permanent repair, as complete dissolution leads to inevitable hernia recurrence. 3, 5
  • Do not automatically exclude mesh based solely on non-viable intestine presence when gross spillage is absent, as infection rates are similar between viable and non-viable bowel cases. 3, 5

Technical Considerations

  • Ensure adequate fascial closure before mesh placement, as sublay extra-peritoneal bio-prosthesis placement without anterior fascia closure increases wound complications (OR = 0.33). 7
  • In severely obese patients (BMI >50): Consider hybrid IPOM-plus combining open and laparoscopic approaches for safe trocar insertion and reduced wound strain. 9

Expected Outcomes

Efficacy

  • Recurrence rates: IPOM-plus demonstrates significantly lower recurrence (OR = 0.51) with follow-up times significantly influencing outcomes (OR = 0.50, p = 0.0004). 1
  • Seroma reduction: 52% reduction in seroma formation (OR = 0.48) compared to standard IPOM. 1
  • Mesh bulging: 92% reduction in mesh bulging (OR = 0.08) with fascial closure. 1

Safety Profile

  • Complication rate: 5.1% overall complication rate in laparoscopic ventral hernia repair. 8
  • Infection rate: 1.7% infection rate in clean/clean-contaminated fields. 8
  • Hospital stay: Reduced postoperative stay compared to open repair. 8

Related Questions

How to manage an umbilical fat-containing hernia with multi-focal hernia and diastasis using physiologic mesh and IPOM approach?
In a medically stable adult with a 2–10 cm primary or incisional ventral hernia, no contamination, and able to tolerate general anesthesia and laparoscopy, what is the recommended operative technique (intraperitoneal on‑lay mesh), mesh type, fixation method, peri‑operative antibiotic prophylaxis, and postoperative pain and activity management?
What is the clinical significance and management of the Linea Alba in hernias?
What is the recommended approach for robotic-assisted laparoscopic repair of incisional hernia with Intraperitoneal Onlay Mesh (IPOM)?
What medical specialty typically repairs hernias?
What is the endoscopic appearance of gastric atrophic mucosa?
What is the appropriate evaluation and management for a Baker's cyst?
What is the appropriate colistin dosing regimen (loading dose, maintenance dose, renal adjustments, and duration) for an adult with a multidrug‑resistant liver abscess and no severe renal impairment?
Can colistin be injected directly into a liver abscess in an adult with a multidrug‑resistant infection and normal renal function?
Is semaglutide (Ozempic) safe for weight loss in a healthy 15‑year‑old adolescent?
What is the recommended levothyroxine (thyroxine) tablet dose based on body weight for adults, children, and special populations such as the elderly, patients with cardiovascular disease, and pregnant patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.